Form 4 for SYK Stryker Corporation
Accepted 2022-12-05 00:00:00 ET · period of report 2022-12-02 · accession 0000310764-22-000116 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-12-05 | 2022-12-02 | SYK | Lobo Kevin | COB, CEO, Dir | S - Sale+OE | $239.68 | -67.2K | 80.8K | -45% | -$16.11M |
| D | 2022-12-05 | 2022-12-02 | SYK | Lobo Kevin | COB, CEO, Dir | F - Tax | $240.77 | -120.2K | 148.0K | -45% | -$28.95M |
| D | 2022-12-05 | 2022-12-02 | SYK | Lobo Kevin | COB, CEO, Dir | M - OptEx | $64.01 | +187.5K | 268.2K | +232% | +$12.00M |
| D | 2022-12-05 | 2022-12-02 | SYK | Lobo Kevin | COB, CEO, Dir | M - OptEx | $64.01 | -187.5K | 0 | -100% | -$12.00M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-12-02 | S | D | 43,809 | $239.43 | 104,193 | D | — | — | (F2) The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $239.00 to $239.925, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein. |
| 2 | Common | Common Stock | 2022-12-02 | F | D | 120,238 | $240.77 | 148,002 | D | — | — | |
| 3 | Common | Common Stock | 2022-12-02 | M | A | 187,470 | $64.01 | 268,240 | D | — | — | (F1) Includes 2,467 shares of Stryker Common Stock acquired pursuant to Stryker Corporation's Employee Stock Purchase Plan ("ESPP") as of September 30, 2022, the date of the latest available statement of the reporting person's ESPP holdings. |
| 4 | Common | Common Stock | 2022-12-02 | S | D | 23,423 | $240.16 | 80,770 | D | — | — | (F3) The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $240.015 to $240.36, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein. |
| 5 | Derivative | Employee Stock Option granted 02/13/2013 (right to buy) | 2022-12-02 | M | D | 187,470 | $64.01 | 0 | D | $64.01 · — to 2023-02-12 | 187,470 Common Stock | (F4) Employee stock option granted pursuant to the Stryker Corporation 2011 Long-Term Incentive Plan, exercisable as to 20% on each of the first five anniversaries of the date of grant. |